307(top 1%)
papers
37.7K(top 0.1%)
citations
50(top 1%)
h-index
194(top 0.1%)
g-index
365
all documents
41.8K
doc citations
3.2K
citing journals

Top Articles

#TitleJournalYearCitations
1The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia201112,681
2The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia20117,498
3Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia20115,550
4National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseAlzheimer's and Dementia20121,968
5Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's and Dementia20111,547
6Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspectiveAlzheimer's and Dementia20151,187
7Neuropsychiatric symptoms in Alzheimer's diseaseAlzheimer's and Dementia2011752
8Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup2011531
9Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkersLancet Neurology, The2017464
10Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationAlzheimer's and Dementia2013443
11Consensus classification of posterior cortical atrophyAlzheimer's and Dementia2017423
12Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care settingAlzheimer's and Dementia2013418
13Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or DementiaJAMA - Journal of the American Medical Association2019391
14Research priorities to reduce the global burden of dementia by 2025Lancet Neurology, The2016284
15World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementiaAlzheimer's and Dementia2020257
16Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasLancet Neurology, The2020254
17White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunitiesAlzheimer's and Dementia: Translational Research and Clinical Interventions2019250
18Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s AssociationJournal of Nuclear Medicine2013248
19Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigmsAlzheimer's and Dementia: Translational Research and Clinical Interventions2017240
20Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus ConferenceJournal of the American Medical Directors Association2015222
21Down syndrome and Alzheimer's disease: Common pathways, common goalsAlzheimer's and Dementia2015218
22New insights into atypical Alzheimer's disease in the era of biomarkersLancet Neurology, The2021214
23Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease researchAlzheimer's and Dementia2015205
24The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's diseaseAlzheimer's and Dementia2022169
25Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's diseaseAlzheimer's and Dementia2018163
26The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioningAlzheimer's and Dementia2021140
27Developing novel blood‐based biomarkers for Alzheimer's diseaseAlzheimer's and Dementia2014138
28Alzheimer’s Association Dementia Care Practice RecommendationsGerontologist, The2018133
29Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke WorkshopAlzheimer's and Dementia2020108
30Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trialsAlzheimer's and Dementia: Translational Research and Clinical Interventions2018104
31Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's diseaseAlzheimer's and Dementia2013100
32The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research RoundtableAlzheimer's and Dementia201898
33Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndromeAlzheimer's and Dementia201794
34Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's diseaseAlzheimer's and Dementia201693
35The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutionsAlzheimer's and Dementia201691
36Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and educationAlzheimer's and Dementia201390
37Measuring cognition and function in the preclinical stage of Alzheimer's diseaseAlzheimer's and Dementia: Translational Research and Clinical Interventions201887
38Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working groupAlzheimer's and Dementia202284
39Optimizing Coding and Reimbursement to Improve Management of Alzheimer's Disease and Related DementiasJournal of the American Geriatrics Society200283
40Caregiver Outcomes of Partners in Dementia Care: Effect of a Care Coordination Program for Veterans with Dementia and Their Family Members and FriendsJournal of the American Geriatrics Society201382
41Revolutionizing Alzheimer's disease and clinical trials through biomarkersAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring201580
42Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseAlzheimer's and Dementia201477
43Assessment of cognition in early dementiaAlzheimer's and Dementia201175
44Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?Alzheimer's and Dementia201473
45Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussionsNature Reviews Neurology201565
46The case for low-level BACE1 inhibition for the prevention of Alzheimer diseaseNature Reviews Neurology202165
472014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease201464
48Alzheimer's Disease prevalence, costs, and prevention for military personnel and veteransAlzheimer's and Dementia201456
49Building a roadmap for developing combination therapies for Alzheimer’s diseaseExpert Review of Neurotherapeutics201554
50The Public Health Road Map to Respond to the Growing Dementia CrisisInnovation in Aging202054